Literature DB >> 12218709

Cerebral blood flow changes in depressed patients after treatment with repetitive transcranial magnetic stimulation: evidence of individual variability.

Stephen E Nadeau1, Karin J M McCoy, Gregory P Crucian, Richard A Greer, Fabian Rossi, Dawn Bowers, Wayne K Goodman, Kenneth M Heilman, William J Triggs.   

Abstract

OBJECTIVE: To elucidate the neural mechanisms of depression.
BACKGROUND: Despite extensive study, the neurophysiology of the brain's state(s) corresponding to depression remains uncertain.
METHODS: HMPAO single photon emission computed tomographic (SPECT) scans were obtained from eight adults diagnosed with major depression resistant to medication (average age 51 years; 4 men) before and immediately after 10 days of 20 Hz repetitive transcranial magnetic stimulation (rTMS) (2000 stimuli/daily 30' treatment). To maximize the likelihood that SPECT scans reflected the state of depression, rather than uncontrolled responses of patients to poorly constrained environments, HMPAO was administered while subjects performed a simple task involving continuous monitoring of the direction of a large arrow on a computer screen and continuously tapping with the left or right index finger according to the direction of the arrow. Mean baseline Beck Depression Inventory (BDI) score was 27.4 (SD = 8.3) and mean posttreatment BDI score was 17.5 (SD = 8.5).
RESULTS: Treatment responders (defined by reduction in BDI score of > or = 30%) had significantly less pretreatment blood flow in the left amygdala compared with nonresponders. Responders demonstrated two patterns of change in regional blood flow with treatment: a reduction in orbitofrontal blood flow and/or a reduction in anterior cingulate blood flow. Nonresponders did not demonstrate any regional changes in blood flow with treatment.
CONCLUSIONS: These results suggest that there may be either more than one state of depression, or that depression may be associated with more than one pattern of psychologic activity, which in turn defines the depressive experience for individual patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218709

Source DB:  PubMed          Journal:  Neuropsychiatry Neuropsychol Behav Neurol        ISSN: 0894-878X


  10 in total

Review 1.  Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Authors:  Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

2.  Baseline brain metabolism in resistant depression and response to transcranial magnetic stimulation.

Authors:  Marie-Laure Paillère Martinot; Jean-Luc Martinot; Damien Ringuenet; André Galinowski; Thierry Gallarda; Frank Bellivier; Jean-Pascal Lefaucheur; Hervé Lemaitre; Eric Artiges
Journal:  Neuropsychopharmacology       Date:  2011-08-17       Impact factor: 7.853

3.  Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression.

Authors:  Raphaelle Richieri; Laurent Boyer; Jean Farisse; Cecile Colavolpe; Olivier Mundler; Christophe Lancon; Eric Guedj
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-07       Impact factor: 9.236

4.  Fractional anisotropy changes after several weeks of daily left high-frequency repetitive transcranial magnetic stimulation of the prefrontal cortex to treat major depression.

Authors:  F Andrew Kozel; Kevin A Johnson; Ziad Nahas; Paul A Nakonezny; Paul S Morgan; Berry S Anderson; Samet Kose; Xingbao Li; Kelvin O Lim; Madhukar H Trivedi; Mark S George
Journal:  J ECT       Date:  2011-03       Impact factor: 3.635

5.  The restoration after repetitive transcranial magnetic stimulation treatment on cognitive ability of vascular dementia rats and its impacts on synaptic plasticity in hippocampal CA1 area.

Authors:  Fei Wang; Xin Geng; Hua-Ying Tao; Yan Cheng
Journal:  J Mol Neurosci       Date:  2009-12-02       Impact factor: 3.444

Review 6.  Therapeutic options for treatment-resistant depression.

Authors:  Richard C Shelton; Olawale Osuntokun; Alexandra N Heinloth; Sara A Corya
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

Review 7.  Advances in the treatment of depression.

Authors:  Paul E Holtzheimer; Charles B Nemeroff
Journal:  NeuroRx       Date:  2006-01

8.  Altered functional connectivity density in major depressive disorder at rest.

Authors:  Bin Zhang; Meng Li; Wen Qin; Liliana Ramona Demenescu; Coraline Danielle Metzger; Bernhard Bogerts; Chunshui Yu; Martin Walter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-08-12       Impact factor: 5.270

Review 9.  Biological markers in noninvasive brain stimulation trials in major depressive disorder: a systematic review.

Authors:  Thiago M Fidalgo; J Leon Morales-Quezada; Guilherme S C Muzy; Noelle M Chiavetta; Mariana E Mendonca; Marcus V B Santana; Oscar F Goncalves; Andre R Brunoni; Felipe Fregni
Journal:  J ECT       Date:  2014-03       Impact factor: 3.635

Review 10.  Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities.

Authors:  Renana Eitan; Bernard Lerer
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.